Palvella Therapeutics
Latest round
- Series D
Last raised
- Dec 2022
Total raised
- $55M
Investors
- 11
About Palvella Therapeutics
is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare genetic skin diseases with no FDA-approved treatments. In October 2025, Palvella Therapeutics, Inc.S. Food and Drug Administration.
Who invested in Palvella Therapeutics
11 investors across 2 rounds
See all investors in Palvella Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Palvella Therapeutics
Who invested in Palvella Therapeutics?
Palvella Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Palvella Therapeutics raised?
Palvella Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Palvella Therapeutics last raise money?
Palvella Therapeutics's most recent round on record is a Series D, in Dec 2022.
What does Palvella Therapeutics do?
is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare genetic skin diseases with no FDA-approved treatments.
Where is Palvella Therapeutics headquartered?
Palvella Therapeutics is headquartered in Wayne, US.
Which VCs invest in companies like Palvella Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Palvella Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Palvella Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.